Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HTLV-1”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Early research (Phase 1)UnknownNCT01640002
What this trial is testing

A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder

Who this might be right for
Overactive Bladder Associated With HTLV-1
Hospital Universitário Professor Edgard Santos 42
Early research (Phase 1)Study completedNCT01169298
What this trial is testing

A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

Who this might be right for
Adult T-cell Leukemia-LymphomaPeripheral T-cell Lymphoma
Celgene 13
Early research (Phase 1)Study completedNCT05240612
What this trial is testing

A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM)

Who this might be right for
HTLV-1-Associated Myelopathy (HAM)
Tanabe Pharma Corporation 15
Very early researchStudy completedNCT02655471
What this trial is testing

Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection

Who this might be right for
HTLV-I InfectionsTropical Spastic Paraparesis
Universidad Peruana Cayetano Heredia 10
Testing effectiveness (Phase 2)Study completedNCT02631746
What this trial is testing

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+3 more
National Cancer Institute (NCI) 3
Early research (Phase 1)Study completedNCT00076843
What this trial is testing

Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

Who this might be right for
HTLV-1
National Institute of Neurological Disorders and Stroke (NINDS) 9
Not applicableEnded earlyNCT00519181
What this trial is testing

Safety and Efficiency Study of Valproic Acid In HAM/TSP

Who this might be right for
HTLV-I-Associated Myelopathy
University Hospital Pierre Zobda-Quitman 19
Testing effectiveness (Phase 2)Study completedNCT00061048
What this trial is testing

Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Acute T-Cell Leukemia-Lymphoma
National Cancer Institute (NCI) 29
Very early researchStudy completedNCT01867320
What this trial is testing

Raltegravir for HAM/TSP

Who this might be right for
HTLV-I Infection
National Institute of Neurological Disorders and Stroke (NINDS) 19
Testing effectiveness (Phase 2)Study completedNCT00041327
What this trial is testing

Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium 19
Testing effectiveness (Phase 2)Study completedNCT00481871
What this trial is testing

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Who this might be right for
Relapsed or Refractory Lymphoproliferative MalignanciesHodgkin's LymphomaPeripheral T-cell Lymphoma+2 more
Acrotech Biopharma Inc. 119
Post-approval studies (Phase 4)Study completedNCT06616675
What this trial is testing

Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1

Who this might be right for
HTLV-1Overactive Bladder Syndrome
Hospital Universitário Professor Edgard Santos 42
Not applicableStudy completedNCT01149837
What this trial is testing

Evaluation of InnoLIA HTLV I/II Score

Who this might be right for
Human T-Lymphotrophic Virus Type I and/or Type II
Creative Testing Solutions 3,305
Testing effectiveness (Phase 2)Looking for participantsNCT06698003
What this trial is testing

Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Who this might be right for
T-Cell Leukemia/Lymphoma, AdultT-cell Leukemia/LymphomaT-cell Leukemia+1 more
Memorial Sloan Kettering Cancer Center 134
Testing effectiveness (Phase 2)Study completedNCT01000285
What this trial is testing

EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma

Who this might be right for
Leukemia-Lymphoma, Adult T-Cell
Washington University School of Medicine 18
Not applicableStudy completedNCT00339638
What this trial is testing

Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1

Who this might be right for
Human T-Lymphoma Virus Type I
National Cancer Institute (NCI) 228
Large-scale testing (Phase 3)Study completedNCT00681980
What this trial is testing

Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)

Who this might be right for
Paraparesis Spastic Tropical
University of Sao Paulo 60
Not applicableStudy completedNCT02439918
What this trial is testing

Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa

Who this might be right for
HIVHTLV-1Hepatitis C, Chronic
Université de Sherbrooke 839
Not applicableStudy completedNCT01651819
What this trial is testing

Urological Physical Therapy in HTLV-1 With Urinary Symptoms

Who this might be right for
Tropical Spastic ParaparesisHTLV-1
Hospital Universitário Professor Edgard Santos 20
Testing effectiveness (Phase 2)UnknownNCT04004819
What this trial is testing

Rituximab for HTLV-1-associated Myelopathy

Who this might be right for
HTLV-1-associated Myelopathy
First Affiliated Hospital of Fujian Medical University 100
Next Page